Clinical Trial Update: A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

View source ↗

Summary

An ongoing clinical trial update evaluating brentuximab vedotin in pediatric participants with Hodgkin lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)

Snippet

Sponsor: Takeda | Conditions: Hodgkin Lymphoma | Status: RECRUITING